Trials / Completed
CompletedNCT04923568
VR and Chronic Pain Pilot Usability Study
Virtual Reality and Chronic Pain Pilot Usability Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Albert Einstein College of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot feasibility and usability study of a virtual reality device for patients with chronic pain.
Detailed description
The investigators will conduct a study of patients with chronic pain to identify interest in participating in a large VR trial and, for those willing to join the team to test the device in person, to pilot 2 sessions of VR to assess usability and collect preliminary data on pain and mood and to obtain data on patient satisfaction with device use. Researchers expect the entire session to last 45 minutes to 1 hour. All patients recruited will be in the active arm; this is not a randomized pilot study. The intervention being piloted is the EaseVRx - AppliedVR, Los Angeles, CA - VR hardware and software. EaseVRx incorporates evidence-based principles of cognitive behavioral therapy, mindfulness, and pain neuroscience education into an immersive and enhanced biofeedback experience. EaseVRx includes breathing training and relaxation response exercises that activate the parasympathetic nervous system. EaseVRx was designed for at-home use and comes with a sequence of daily immersive experiences, with each VR experience being 2-16 minutes in length (average of 6 minutes). For this pilot, researchers will be doing one in-person session, using two interoceptive VR experiences (out of 56 total).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EaseVRx | Participants will experience 2 sessions of the EaseVRx device for chronic pain |
Timeline
- Start date
- 2021-08-03
- Primary completion
- 2022-10-07
- Completion
- 2022-10-07
- First posted
- 2021-06-11
- Last updated
- 2023-09-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04923568. Inclusion in this directory is not an endorsement.